Article Details

ASCO: Boehringer, OSE offer promising glimpse of the immuno-oncology drug at the heart of their ...

Retrieved on: 2021-05-21 14:03:45

Tags for this article:

Click the tags to see associated articles and topics

ASCO: Boehringer, OSE offer promising glimpse of the immuno-oncology drug at the heart of their .... View article details on hiswai:

Excerpt

That patient maintained a partial response for 27 weeks and is still ... myeloid lineage cells, in turn freeing up the immune system to attack tumors.

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up